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Abstract: Tissue engineering may constitute a promising alternative to current strategies in 
ligament repair, providing that suitable scaffolds and culture conditions are proposed. The 
objective of the present contribution is to present the design and instrumentation of a novel 
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multi-chamber tension-torsion bioreactor dedicated to ligament tissue engineering. A 
preliminary biological evaluation of a new braided scaffold within this bioreactor under 
dynamic loading is reported, starting with the development of a dedicated seeding protocol 
validated from static cultures. The results of these preliminary biological characterizations 
confirm that the present combination of scaffold, seeding protocol and bioreactor may 
enable us to head towards a suitable ligament tissue-engineered construct. 
Keywords: bioreactor; braided scaffold; stem cells; ligament tissue engineering 
 
1. Introduction 
The principle of tissue engineering offers large horizons in the field of reconstructive surgery of the 
musculoskeletal system, providing that: (1) the native biomechanical function of the tissue to repair is 
well defined [1,2]; (2) a biodegradable scaffold able to restore this function and to encourage tissue 
formation is proposed [3–10]; (3) suitable cells are selected [11] and protocols are proposed to scale-up 
and seed them within this scaffold [12–15]; (4) an adapted bioreactor is used both to simulate in vitro 
the tissue implantation and to provide cells with suitable mechanical stimuli [16–21]. However, there 
is still no clear consensus concerning the best solution for each of these steps, thus requiring additional 
intensive and pluridisciplinary research. For some ligaments such as the Anterior Cruciate Ligament 
(ACL) associated with frequent injuries, the range of physiological loadings and the associated strains 
have been well documented [22,23], as well as the properties of the native tissue [24,25]. We have 
recently proposed a novel multilayer braided scaffold made of a copoly(lactic acid-co-(ε-caprolactone)) 
(PLCL) for ligament tissue engineering, and we have brought some evidences about its suitability for 
ACL tissue engineering in terms of morphology [26] and tensile response [27]. The next natural step of 
the approach is to propose protocols enabling a homogeneous seeding of such a scaffold, and to 
imagine a bioreactor able to simulate its implantation and to provide seeded cells with suitable stimuli. 
Although ligaments of the musculoskeletal system are obviously mainly subject to cyclic tensile 
loading, it is now acknowledged that the ACL is also subject to twisting that obviously plays a role in 
the resulting stresses [28,29]. It has been indeed suggested that a knee flexion of 90° could result in 
ACL torsion of more than 35°. The role of torsion in the mechanisms involved in ACL failure has been 
also emphasized [30]. Consequently, it seems that a bioreactor able to simulate in vitro the 
implantation of a scaffold for ligaments should reproduce the physiological tension-torsion cycles. 
Moreover, it is well reported that cell respond both to the strain of their substrate [31,32] and the wall 
shear stress due to the circulation of physiological fluid [33]. Cyclic loading enable to provide the cells 
with both types of stimuli, as long as (1) external loads are transferred to the cells through the scaffold 
deformation; (2) stretching a fluid-saturated porous media such as the scaffold obviously result in fluid 
flow, which may be adjusted by playing on the frequency of cyclic loads [34]. Particularly, we have 
previously shown [35] that the braided scaffold was compatible with a computer-aided approach that 
may enable to quantify these local signals that are not measurable experimentally. The dynamic culture 
of such a scaffold under tension-torsion cycles, combined with these computer simulations, could 
therefore bring crucial information regarding the evaluation of the effects of these local stimuli and 
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their magnitudes on cellular activity. However, one of the major difficulties associated with the 
required experimental evaluations lies in the large variability inherently related to biological material. 
Indeed, characterizations of tissue engineering constructs must be largely repeated in order to draw 
conclusions about the suitability of a scaffold or a culture protocol, and a large amount of experiments 
are therefore necessary. The multi-chamber bioreactor described in the following sections enables to 
address this variability by simultaneously co-culturing several samples under identical conditions 
(mechanical and biochemical). Alternatively, the multi-chamber bioreactor may be used to compare 
different protocols (e.g., in terms of culture medium composition or scaffold coating) under similar 
mechanical loading.  
The evaluation of such a bioreactor must obviously involves the culture of a large sample of 
scaffolds over a long period, which firstly requires that adapted seeding protocols are proposed in 
order to get an initial homogeneous cell distribution. As far as such seeding procedure is concerned, it 
has been emphasized in the literature that cellular penetration was preferable when a rationally-designed 
scaffold was used rather than a random porous structure [36], and that morphological gradients from 
core to periphery were suitable as far as nutrients supply is concerned [37]. These particular statements 
have strongly motivated the choice of the multilayer braided structure that will be used in the present 
study, which clearly offers non-homogeneous pore sizes from the braid axis to the braid periphery, as 
emphasized previously [35]. It is then our hypothesis that this structure could enable good cellular 
penetration and cell colonization, even without the perfusion of a cell suspension.  
The objective of the present contribution is to present the novel multi-chamber tension-torsion 
bioreactor that has been designed in our team in order to meet the requirements for ligament tissue 
engineering. We will then present a preliminary biological evaluation of the bioreactor: firstly, the 
seeding procedure enabling a homogeneous cell distribution within the multilayer braided scaffold will 
be described and evaluated through static culture; secondly, this procedure will be applied to perform a 
preliminary dynamic culture of the scaffold within the bioreactor. 
2. Materials and Methods 
2.1. Bioreactor Design and Instrumentation 
Our initial goal was to design and build a bioreactor able to (1) co-culture parallel six scaffold 
samples; (2) impose identical, programmable and adjustable loading cycles to the six chambers;  
(3) impose tension, torsion or tension-torsion cycles; (4) co-culture these six samples under identical or 
different biochemical conditions, depending on the objective (i.e., reproducibility study or optimization 
of the culture conditions); (5) provide the samples with a thermo-regulated and sterile environment;  
(6) impose a flow circulation of regulated culture medium in order to provide the samples with 
nutrients and to evacuate wastes; (7) record the evolution of reaction force within the scaffold in 
response to the prescribed displacement. We retained a technical solution in which samples are 
cultured within six separated polycarbonate chambers (see [38]), disposed circularly around a central 
axis, the whole system being placed in a thermoregulated enclosure. The temperature regulation is 
realized through a circulation of hot air, a thermocouple (Prosensor, Amanvillers, France) and a PID 
controller (BMS France, Pringy, France). Sterilized scaffolds are clamped in jaws through a frontal 
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opening in each chamber. Chamber impermeability at the level of the translating upper jaw was 
performed using sterile latex tubes, in order not to restrict the relative translation and rotation between the 
upper jaw and the chambers. 
Tension and torsion loading take advantage of two electric servomotors (Transtechnik, Ahuy, 
France, Figure 1a), driven in an uncoupled way by a servodriver (Delta Electronics, Taipei, Taiwan). 
Translation is performed using an endless screw, controlled by the first motor, activating a tray 
connected to the upper jaws of each chamber (Figure 1b). Rotation of the chambers is performed using 
a gear transmission: the lower jaw of each chamber is connected to a gear driven by the central gear, 
activated by the second motor. The current position in translation and rotation are controlled using a 
magnetic scale and an incremental magnetic encoder ring respectively (ASM, Munich, Germany). A 
feedback on the prescribed displacement and rotation is ensured using these encoders and can be 
recorded throughout the dynamic culture. As far as the reaction force in the scaffolds is concerned, one 
shaft connecting the upper jaw to the translating tray is instrumented using strain gauges (linear 
patterns strain gauges, Vishay Precision Group, Malvern, PA, USA). These strain gauges record the 
deformation within a specific part of the shaft, directly and linearly linked to the forces in the scaffold 
in reaction to the prescribed displacement. This feedback on applied force enables (1) to evaluate 
mechanical properties of the scaffold, such as dynamic creep or fatigue properties, when loaded 
physiologically within a fluid environment; (2) to measure the evolution of scaffold properties due to 
both the fibers degradation and neo-tissue formation. A high-definition camera (Lumenera LM135, 
Ottawa, Canada) is disposed in the enclosure and is synchronized to the loading cycles, in such a way 
that the evolution of the scaffold can be visualized and recorded in time. 
Figure 1. (a) Global scheme of the bioreactor functioning (b) Zoom on one of the six 
bioreactor chambers. 
 
A dedicated acquisition interface has been developed and enables (1) to specify the type, amplitude 
and frequency of the prescribed displacement and their scheduling over several weeks; (2) to acquire 
high resolution pictures synchronized with the loading cycles; (3) to record the prescribed 
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displacement and rotation throughout the dynamic culture; (4) to record the evolution of force applied 
to one scaffold; (5) to manually control the servomotors in order to be compatible with different 
scaffold lengths.  
2.2. Culture Medium Circulation 
As far as the circulation of culture medium is concerned, chambers are connected to buffered 
medium tanks (0.4 liter working volume) and aerated with air containing 5% CO2 through versilic 
silicone tubing, and culture medium circulation is ensured via an external peristaltic pump. The 
buffered medium tank is regulated in pH and pO2 using appropriate sensors (Mettler Toledo, Viroflay, 
France). The six chambers can be connected to identical or different buffered medium tanks, allowing 
performing reproducible or independent studies. In these conditions, a 7-days long evaluation of the 
biochemical regulation has been performed: chambers without scaffolds were mounted in the 
bioreactor regulated at 37 °C and a flow circulation rate of 5 mL per minute was insured. The 
components in contact with the culture medium (chambers, jaws, keys, tanks, tubes and hydraulic 
connections, BioExpert Applikon as well as the culture medium tank equipped with pO2 and pH 
sensors) were firstly sterilized by autoclaving (121 °C, 30 min). Chambers were then mounted in the 
bioreactor and progressively filled with culture medium made of DMEM-F12 and supplemented with 
10% calf fetal serum and 1% (v/v) antibiotics cocktail (Merckmillipore, 10,000 U/mL penicillin G,  
10 mg/mL streptomycin, 25 µg/mL amphotericin B). pO2 and pH were set and controlled at 25% air 
saturation and 7.3 respectively using a controller (Applikon ADI 1030, Schiedam, The Netherlands) 
and were recorded over the 7-days period (BioExpert, Applikon, Schiedam, The Netherlands).  
2.3. Scaffold Fabrication and Preparation 
The bioreactor presented above aims at culturing novel scaffolds for ligament tissue engineering 
recently proposed and evaluated in our group [26]. Briefly, the scaffold is made of concentric braided 
layers of PLCL fibers. We used a commercial copolymer (Purac Biomaterials, Gorinchem,  
The Netherlands) with a lactic acid/ε-caprolactone proportion of 85/15. This copolymer has been 
selected because of its biocompatibility and slow biodegradability, and allows both the brittle behavior 
of polylactic acid and the low stiffness of polycaprolactone to be compensated. PLCL fibers have been 
processed from raw material using a custom plastic extruder enabling the processing of adjustable and 
homogeneous fibers from a small amount of polymer. Fibers have been then arranged into concentric 
circular braids using a custom maypole braider (Composite and Wire Machinery, North Kingstown, 
RI, USA) enabling the processing of braided scaffolds from small lengths of fiber. This architecture 
has been chosen for the following reason: (1) it is deformable in the low strain range but exhibits high 
stiffness for large strains; (2) it offers a network of interconnected pores with a pore size gradient 
which is thought suitable for the migration of cells, the supply in biochemical factors, the evacuation 
of wastes and the formation of ligamentous tissue; (3) it is largely tailorable in terms of morphology 
and mechanics by playing with the number of layers of the structure, the fiber diameters and the 
braiding angle of each layer; (4) it is adapted to computer-aided tissue engineering because of its 
predictable geometry. For the experiments reported below, scaffolds were made of 4 layers of  
16 fibers, with a fiber diameter of 170 µm. For static cultures, a long braid was processed and then cut 
Processes 2014, 2 172 
 
 
into 7 mm long samples using a heat sealer. For dynamic culture, scaffolds were approximately 45 mm 
long in order to allow their fixing, but only the central 30 mm was braided. As far as the sterilization of 
both types of scaffolds is concerned, there were placed in 70% ethanol for 30 min and UV-irradiated 
for another 30 min. They were left to dry in the sterile laminar hood for 12 h and kept sterile until use. 
2.4. Seeding Procedure 
In order to culture such a scaffold within the bioreactor, a suitable seeding procedure enabling a 
homogeneous cell distribution and cellular adhesion within the scaffold was firstly required. We 
therefore selected bone marrow mesenchymal stem cells (bMSC) from Merino sheep and further 
expanded until P3. A cell suspension (200,000 cells in 15 µL of culture medium of the same 
composition as above) was deposited within the periphery of the scaffolds. Due to the pore size 
gradient offered by the scaffold architecture (see [26]), the cell suspension immediately penetrated the 
scaffold center and spread along the scaffold. The seeded scaffolds were placed in the incubator for 
30min after which small amounts of medium were progressively added. The medium was 
supplemented with 100 µg/mL ascorbate-2-phosphate. 
Static culture was then performed during four weeks, the medium being changed 3 times a week. 
Scaffolds (n = 3) were harvested at day 3, 7, 14, 21 and 28 for DNA quantification by using a 
PicoGreen working solution (P11496, Invitrogen, Carlsbad, CA, USA) prepared according to the 
manufacturer’s instructions so as to assess the cell proliferation. As far as the SEM analysis is 
concerned, the samples were fixed in a 2.5% glutaraldehyde solution and then dehydrated in a 
concentration gradient of ethanol and finally carbon coated. For confocal imaging, the constructs were 
fixed in a 4% paraformaldehyde solution in PBS. The cell membrane was permeabilized for 5 min in a 
0.2% triton X solution, cytoskeleton stained for 45 min with a mixture of 0.8 U/mL TRITC-conjugated 
phalloidin and nuclear stained with 5 µg/mL DAPI solution. The biphasic scaffolds were rinsed 
another three times and imaged with a Leica SP5 microscope (TCS SP5 II, Leica, Solms, Germany) 
with a 20× dry objective. 4 µm thick Z-stacks were acquired over a total height of 400–600 µm.  
2.5. A Preliminary Dynamic Culture within the Bioreactor 
Once the seeding procedure validated, similar protocol were applied to seed the scaffolds prior to 
dynamic culture within the bioreactor. The components of the bioreactor were sterilized as described 
previously, and a cell suspension was deposited within two scaffolds. The chambers were then closed 
and placed in an incubator for 30 min in order to enhance cellular adhesion. An additional part fixed to 
both the upper jaw and the chamber was used to restrict their relative movement throughout this phase. 
The whole hydraulic system was then connected to chambers under the laminar air flow hood. 
Chambers were mounted in the bioreactor, and the part used to restrict the jaw translation was removed.  
Two scaffolds were seeded according to the presented protocol with 100 µL of suspended human 
bMSC, using respectively 200,000 and 600,000 cells/100 µL. The scaffolds were cultured 48 h within 
the bioreactor under a circulation of culture medium regulated as described previously. The cultures 
were kept static for the first 24 h, and a planned cyclic loading was then applied (2.5% strain and 10° 
rotation at 1 Hz) during 2 min every 30 min for 10 h. The constructs were then fixed after 48 h as 
previously described and stained with EthD-1 at 4 mM. Scaffold’s images were acquired with a 
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macromultiphoton [38] developed at the PTIBC-IBISA Imaging Core Facility in Nancy, used in 
confocal macroscope mode. This modality uses a Leica Z16 APO A coupled to a Leica SP5-II CFS 
confocal microscope with a 5× objective (NA 0.5). Fifteen micrometer thick Z-stacks were acquired 
over a total height of 2 mm and superposed with a 514 nm excitation wavelength, which permitted to 
visualize both the autofluorescence of polymer fibers and the cellular staining nuclei. 
3. Results and Discussion 
3.1. Bioreactor System 
Our novel multichamber tension-torsion bioreactor has been manufactured in the mechanical 
department of our university. The management of electronic devices and motors and a dedicated  
user-friendly control interface have been also realized in our common services. Sensors (microswitches 
Honeywell, Morristown, NJ, USA) have been added in order to prevent the user to impose 
displacements that would lead bioreactor parts to enter into contact. In comparison to previously 
reported bioreactor [19,39], the system proposed in the present contribution enables the co-culture of 
six scaffolds under tension-torsion (synchronized or not) cyclic loads scheduled over several weeks. 
The final bioreactor configuration is showed below (Figure 2). 
Figure 2. Multi-chamber tension-torsion bioreactor in its final configuration. (a) scaffold 
mounted in a bioreactor chamber (b) entire set-up including command and interface. 
 
Results of the biochemical regulation test indicated that pO2 and pH parameters of the culture 
medium were maintained stable over this 7-days period and no signs of biological contamination were 
noticed. One must however emphasize that the culture medium contained antibiotics which may have 
delayed any potent contamination, without strictly demonstrating the impermeability of the system to 
external contamination. Nevertheless, an identical culture medium composition will be used for 
Thermoregulated enclosure 
Control 
interface 
Command 
 
 
a 
b 
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forthcoming long-term biological cultures. Therefore, we concluded to the ability of the bioreactor to 
prevent contamination. 
3.2. Static Culture 
The results from the DNA quantification (Figure 3) and the confocal and SEM images at different 
time points (Figure 4) clearly show that the cells are able to adhere and proliferate within the scaffold 
when seeded as described above. Cells slightly clustered in the first days, and then spread along the 
whole scaffold. Interestingly, the cells have a tendency to spontaneously orientate in the fiber 
direction. Cellular bridges between fibers appear from day 14, and it is likely that cyclic stretching of 
the scaffold and the corresponding sliding between fibers will impede the phenomenon. Noteworthy, 
there is a substantial variability concerning the DNA values at day 14, indicating that proliferation rate 
differs from one scaffold to another. This variability is largely reduced at day 21. At day 28, the 
decrease in cell number is thought to be due to the obstruction of external pores by ECM, which may 
cause deficiencies in mass transport. Firstly, as seen above, a different scaffold configuration may 
result in bigger pore sizes at the scaffold periphery, reducing the risk of obstruction. Moreover, this 
should not be the case with another scaffold configuration (with higher fiber diameter and/or number 
of layers) under dynamic culture. Indeed, cyclic stretching of the scaffold-even with a small  
frequency-will involve fluid flow (essentially in the radial direction) due to the deformation of the 
saturated porous scaffold. Noteworthy, Computed Fluid Dynamics (CFD) may help to determinate 
such effects, which is currently addressed by our team (see [35]).  
Figure 3. Evolution of DNA from 3 (D3) to 28 (D28) days. 
 
3.3. Preliminary Dynamic Culture in the Bioreactor 
The qualitative results issued from the culture of constructs within our novel bioreactor indicated 
that the cells satisfyingly adhered to the scaffold fibers as a result of the dedicated seeding protocol, 
and that they were still present on a large extent after the prescribing of cyclic loads and the circulation 
of culture medium (Figure 5). No contamination was observed during this period. We observed that 
cells were present in a larger amount when the cell suspension was more concentrated, but were not 
more homogeneously distributed. We also observed that cells were gathered into clusters, which may 
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indicate that (1) the seeding procedure did not perfectly enable to distribute homogeneously the cells 
within the whole scaffold, and/or (2) the cells have clustered under dynamic loading. The second 
hypothesis is unlikely, as long as this effect has been also observed in the first days of static culture.  
Figure 4. Images issued from confocal microscopy (up) and scanning electron microscopy 
(down) at (a) Day 3 (b) Day 7 (c) Day 14 (d) Day 21 (e) Day 28. 
 
Figure 5. Macroconfocal images of scaffolds cultured three days in the bioreactor and 
seeded with (a) 200,000 cells (b) 600,000 cells. 
 
This may be due to the well-known hydrophobic properties of PLCL [40] that tends to repulse the 
cell suspension. This effect could be counterbalanced in the future by initially coating the scaffolds 
with fibronectin [4,41], RGD peptides [42] or collagen [43,44], which is currently tested in our team. 
These preliminary results should be corroborated in the future by performing repeated in vitro 
dynamic culture, which will be precisely made possible by the use of the multi-chamber bioreactor. 
Some future enhancements will be envisaged starting from the present study. Firstly, numerical studies 
that we recently reported on the braided scaffold [26,27] will be used to determine the best-suited 
design for the specific application that we target here. We have indeed observed that, for instance, the 
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pore size distribution of the scaffolds used in the present study may not perfectly prevent the 
obstruction of external pores after 28 days. Particularly, we should integrate in these studies the effect 
of sterilizing protocol on the mechanical properties of PLCL fibers, in order to take into account this 
effect during the numerical optimization of the scaffold properties.  
4. Conclusions 
The present contribution reported recent advances towards the development of a tissue-engineered 
ligament, by presenting a novel dedicated multi-chamber tension-torsion bioreactor and its first 
preliminary evaluation using a recently reported multilayer braided scaffold. Results of static cultures 
have enabled to conclude that the proposed seeding protocols led to a high cellular adhesion and 
proliferation, and to the whole scaffold colonization in 28 days. This protocol has been applied to 
perform a preliminary dynamic culture, which results in the adhesion of a large amount of cells after 
48 days of dynamic culture. The bioreactor will be used in the future in order to optimize and evaluate 
scaffold properties, and presents large possibilities to be extended to the dynamic culture of other 
tissues such as cartilage or skin. It is the conviction of the authors that these preliminary results could 
benefit the tissue engineering community in the research of the most suited approach towards the 
design of a tissue-engineered construct.  
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